Clinical Trial: A Repeat Ascending Dosing Study of the Safety and Clinical Activity of R-3750 in Patients With Mild to Moderate COPD

U.S., July 23 -- ClinicalTrials.gov registry received information related to the study (NCT07076290) titled 'A Repeat Ascending Dosing Study of the Safety and Clinical Activity of R-3750 in Patients With Mild to Moderate COPD' on July 14.

Brief Summary: The goal of this study is to determine the safety and tolerability of orally taken probiotic (R-3750) in patients with mild to moderate chronic obstructive pulmonary disease (COPD)

Study Start Date: Nov. 01, 2025

Study Type: INTERVENTIONAL

Condition: COPD (Chronic Obstructive Pulmonary Disease) COPD Exacerbation COPD Exacerbation Acute

Intervention: DRUG: R-3750

R-3750 DP; Lactococcus lactis expressing Surface Layer Protein A (SlpA)

Recruitment Status: NOT_YET_RECRUITING

Sponsor: R...